PAVmed (PAVM) Net Cash Flow (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.96% |
| Sep 30, 2025 | -170.59% |
| Jun 30, 2025 | -14.30% |
| Mar 31, 2025 | 256.19% |
| Jun 30, 2024 | -100.63% |
| Mar 31, 2024 | 187.12% |
| Dec 31, 2023 | 37.06% |
| Sep 30, 2023 | 11.24% |
| Jun 30, 2023 | -227.07% |
| Mar 31, 2023 | 155.96% |
| Dec 31, 2022 | -103.64% |
| Sep 30, 2022 | -2,111.54% |
| Jun 30, 2022 | 103.32% |
| Mar 31, 2022 | -131.37% |
| Dec 31, 2021 | 780.13% |
| Sep 30, 2021 | -9.99% |
| Jun 30, 2021 | -117.05% |
| Mar 31, 2021 | 249.10% |
| Dec 31, 2020 | 638.91% |
| Sep 30, 2020 | 173.47% |
| Jun 30, 2020 | -165.72% |
| Mar 31, 2020 | 18.38% |
| Dec 31, 2019 | 175.49% |
| Sep 30, 2019 | -203.42% |
| Jun 30, 2019 | 167.41% |
| Mar 31, 2019 | -295.52% |
| Dec 31, 2018 | 45.56% |
| Sep 30, 2018 | -124.95% |
| Jun 30, 2018 | 258.21% |
| Mar 31, 2018 | 232.94% |
| Dec 31, 2017 | -152.04% |
| Sep 30, 2017 | 467.82% |
| Jun 30, 2017 | -357.40% |
| Mar 31, 2017 | 126.60% |
| Dec 31, 2016 | 2.53% |
| Sep 30, 2016 | 18.17% |
| Jun 30, 2016 | -183.93% |
| Mar 31, 2016 | 18.03% |
| Dec 31, 2015 | -172.51% |
| Sep 30, 2015 | 530.44% |
| Jun 30, 2015 | -88.97% |